Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Fresenius Medical Care AG (FMS) Net Income towards Common Stockholders: 2009-2024

Historic Net Income towards Common Stockholders for Fresenius Medical Care AG (FMS) over the last 16 years, with Dec 2024 value amounting to $574.8 million.

  • Fresenius Medical Care AG's Net Income towards Common Stockholders rose 25.59% to -$739.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.8 billion, marking a year-over-year increase of 12.61%. This contributed to the annual value of $574.8 million for FY2024, which is 6.49% up from last year.
  • As of FY2024, Fresenius Medical Care AG's Net Income towards Common Stockholders stood at $574.8 million, which was up 6.49% from $539.8 million recorded in FY2023.
  • Fresenius Medical Care AG's 5-year Net Income towards Common Stockholders high stood at $1.3 billion for FY2020, and its period low was $539.8 million during FY2023.
  • For the 3-year period, Fresenius Medical Care AG's Net Income towards Common Stockholders averaged around $608.1 million, with its median value being $574.8 million (2024).
  • As far as peak fluctuations go, Fresenius Medical Care AG's Net Income towards Common Stockholders plummeted by 38.13% in 2022, and later rose by 6.49% in 2024.
  • Over the past 5 years, Fresenius Medical Care AG's Net Income towards Common Stockholders (MRY) stood at $1.3 billion in 2020, then decreased by 13.72% to $1.1 billion in 2021, then crashed by 38.13% to $709.7 million in 2022, then dropped by 23.95% to $539.8 million in 2023, then rose by 6.49% to $574.8 million in 2024.
  • Its last three reported values are $574.8 million in FY2024, $539.8 million for FY2023, and $709.7 million during FY2022.